Measurement of myeloid cell immune suppressive activity

Current Protocols in Immunology

Volumn , Issue SUPPL.91, 2010, Pages

  Dolcetti, Luigi ^a   Peranzoni, Elisa ^a   Bronte, Vincenzo ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Adoptive cell transfer; Chromium release test; Immunomagnetic sorting; Immunosuppression; MDSC; Thymidine incorporation

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL FUNCTION; CELL VIABILITY; CELLULAR IMMUNITY; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; SPLEEN CELL; T LYMPHOCYTE; TRANSGENE;

EID: 79953223017     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1417s91     Document Type: Article

References (26)

1. Azarov, I., Huang, K.T., Basu, S., Gladwin, M.T., Hogg, N., and Kim-Shapiro, D.B. 2005. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J. Biol. Chem. 280:39024-39032.
2. Bronte, V. and Zanovello, P. 2005. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5:641-654.
3. Bronte, V. 2009. Myeloid-derived suppressor cells in inflammation: Uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 39:2670-2672.
4. Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N.P., and Zanovello, P. 2000. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96:3838-3846.
5. Bronte, V., Cingarlini, S., Marigo, I., De Santo, C., Gallina, G., Dolcetti, L., Ugel, S., Peranzoni, E., Mandruzzato, S., and Zanovello, P. 2006. Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: A novel target for therapeutic intervention. Immunol. Invest. 35:327-357.
6. Dolcetti, L., Marigo, I., Mantelli, B., Peranzoni, E., Zanovello, P., and Bronte, V. 2008. Myeloid-derived suppressor cell role in tumor-related inflammation. Cancer Lett. 267:216-225.
7. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M., Winkels, G., Traggiai, E., Casati, A., Grassi, F., and Bronte, V. 2009. Hierarchy of immunosup-pressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40:22-35.
8. Gabrilovich, D.I. and Nagaraj, S. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9:162-174.
9. Gabrilovich, D.I., Velders, M.P., Sotomayor, E.M., and Kast, W.M. 2001. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166:5398-5406.
10. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M.P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., Bicciato, S., and Bronte, V. 2006. Tumors induce a subset of inflammatory monocytes with immuno-suppressive activity on CD8+ T cells. J. Clin. Invest. 116:2777-2790.
11. Greifenberg, V., Ribechini, E., Rossner, S., and Lutz, M.B. 2009. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 39:2865-2876.
12. Huang, B., Pan, P.Y., Li, Q., Sato, A.I., Levy, D.E., Bromberg, J., Divino, C.M., and Chen, S.H. 2006. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66:1123-1131.
13. Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., Lackner, A., Alvarez, X., Ochoa, A., Chen, L., and Zou, W. 2006. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 203:871-881.
14. Loke, P., MacDonald, A.S., Robb, A., Maizels, R.M., and Allen, J.E. 2000. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 30:2669-2678.
15. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., Calabrese, F., Basso, G., Zanovello, P., Cozzi, E., Mandruzzato, S., and Bronte V. 2010. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32:790-802.
16. Morgan, D.J., Liblau, R., Scott, B., Fleck, S., McDevitt, H.O., Sarvetnick, N., Lo, D., and Sherman, L.A. 1996. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157:978-983.
17. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., and Van Ginderachter, J.A. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111:4233-4244.
18. Nagaraj, S. and Gabrilovich, D.I. 2008. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res. 68:2561-2563.
19. Ribechini, E., Leenen, P.J., and Lutz, M.B. 2009. Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells. Eur. J. Immunol. 39:3538-3551.
20. Rodriguez, P.C., Quiceno, D.G., Zabaleta, J., Ortiz, B., Zea, A.H., Piazuelo, M.B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E.M., Antonia, S., Ochoa, J.B., and Ochoa, A.C. 2004. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64:5839-5849.
21. Rodriguez, P.C., Hernandez, C.P., Quiceno, D., Dubinett, S.M., Zabaleta, J., Ochoa, J.B., Gilbert, J., and Ochoa, A.C. 2005. Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 202:931-939.
22. Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., and Bronte, V. 2004. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. 53:64-72.
23. Sica, A. and Bronte, V. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117:1155-1166.
24. Solinas, G., Germano, G., Mantovani, A., and Allavena, P. 2009. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86:1065-1073.
25. Yang, R., Cai, Z., Zhang, Y., Yutzy, W.H., Roby, K.F., and Roden, R.B. 2006. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res. 66:6807-6815.
26. Youn, J.I., Nagaraj, S., Collazo, M., and Gabrilovich, D.I. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181:5791-5802.